CSMG Technologies Updates Shareholders on Key Developments, Including Recent U.S. FDA and European CE Mark Clearance for Live Tissue Connect Surgical Device, Targets Initial Sales
CORPUS CHRISTI, Texas--(BUSINESS WIRE)--CSMG Technologies, Inc. (OTCBB: CTGI) President and CEO, Donald S. Robbins issued the following letter to shareholders.
